Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report

Detalles Bibliográficos
Autores principales: Michot, J.-M., Albiges, L., Chaput, N., Saada, V., Pommeret, F., Griscelli, F., Balleyguier, C., Besse, B., Marabelle, A., Netzer, F., Merad, M., Robert, C., Barlesi, F., Gachot, B., Stoclin, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136869/
https://www.ncbi.nlm.nih.gov/pubmed/32247642
http://dx.doi.org/10.1016/j.annonc.2020.03.300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136869/
https://www.ncbi.nlm.nih.gov/pubmed/32247642
http://dx.doi.org/10.1016/j.annonc.2020.03.300

Ejemplares similares